By reducing PDPN levels, we may have disrupted inflammatory signaling pathways that are activated in response to T2DM-induced stress, thereby mitigating the neuroinflammatory response and protecting neurons from damage. This evidence concerns the gene PDPN and type 2 diabetes mellitus.